When will the FDA approve leriglitazone?

A Phase 2 clinical trial testing leriglitazone in people with Friedreich’s ataxia has been completed, but it didn’t meet its main efficacy goal. Because the safety and efficacy of leriglitazone haven’t been fully established, it’s not known if or when the treatment will be approved in the U.S.